Treatment decision-making process of men with newly diagnosed localized prostate cancer: The role of multidisciplinary approach in patient engagement

Published on Apr 18, 2019in Mediterranean Journal of Clinical Psychology
· DOI :10.6092/2282-1619/2019.7.1997
Lara Bellardita10
Estimated H-index: 10
Silvia Villa6
Estimated H-index: 6
+ 4 AuthorsRiccardo Valdagni51
Estimated H-index: 51
The diagnosis of prostate cancer (PCa) often represents a stressful event. In addition to the psychological distress related to the diagnosis, patients face challenging health decisions: in fact, besides radical  treatments, Active Surveillance may represent an option for patients with diagnosis of localized PCa. A multidisciplinary clinical approach seems to represent the suitable organizational model to meet such a requirement, optimising the therapeutic outcome for PCa patients.The present study is a qualitative examination of the treatment decision-making process of men with a newly diagnosed localized PCa who received a multidisciplinary clinical consultation. Results suggest that a multidisciplinary approach may satisfy patients’ need to be comprehensively informed about all their chances and options of curing and managing the disease. Together with information, patients need to build a therapeutic relationship with the physicians in order to share their treatment decision-making experience. If this does not occur, frustration, confusion and other negative emotions may emerge.
📖 Papers frequently viewed together
2 Citations
1 Citations
1 Author (Ronald C. Chen)
5 Citations
Cited By1
#1Allan Ben Smith (UNSW: University of New South Wales)H-Index: 17
#2Orlando Rincones (UNSW: University of New South Wales)H-Index: 3
Last. Afaf Girgis (UNSW: University of New South Wales)H-Index: 67
view all 10 authors...
Abstract null null Background null Decisional conflict and post-treatment decisional regret have been documented in men with localised prostate cancer (LPC). However, there is limited evidence regarding decisional outcomes associated with the choice between robotic-assisted radical prostatectomy (RARP) and radiotherapy, when both treatment options are available in the public health system. There is increasing support for multidisciplinary approaches to guide men with LPC in their decision-making...